MET, Human (Emibetuzumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-MET, Human (Emibetuzumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityMET, Human (Emibetuzumab biosimilar)
CloneEmibetuzumab
Host SpeciesRecombinant Mouse
Reactive Specieshuman
IsotypeIgG4 kappa
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
ApplicationsFuncS, IF, Neut, ELISA, FCM, IP, WB, PK, Activ
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human MET Recombinant Antibody (Emibetuzumab). Emibetuzumab (INN) (LY2875358) is a humanized monoclonal antibody designed for the treatment of cancer. It is in phase II trials for patients with NSCLC. This drug was developed by Eli Lilly & Company.
Immunogenn/a
Other NamesAnti-MET Recombinant Antibody, Research Grade Emibetuzumab, Anti-Human MET Recombinant Antibody(Emibetuzumab), LA480, LY-2875358, Antibody Drug Analogues, Monoclonal Antibody, YR1337, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 1365287-97-3
Catalog #YR1337
Priceplease inquire
Order / More InfoMET, Human (Emibetuzumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.